Seaport Hotel & World Trade Center - Boston, MA
There is growing excitement and momentum in the field fuelled by two approved CAR-T products moving full steam ahead to global approval. However, despite these amazing achievements, both drugs are currently struggling on the market and have only treated a handful of patients to date due to challenges in manufacturing scale up, the ability to meet patient demands alongside payers and healthcare providers who are unable to make this therapy widely available.
The CAR-TCR Summit promises to encapsulate this excitement whilst outlining the key challenges limiting commercial and clinical products, providing you with a comprehensive understanding of the full pharmaceutical value chain of CAR-TCR therapies.
